Evidence map›Paper›PMID 31594918›Full record

ArticleTranslational psychiatry2019

Neurobehavioral phenotype of autism spectrum disorder associated with germline heterozygous mutations in PTEN.

Robyn M Busch, Siddharth Srivastava, Olivia Hogue, Thomas W Frazier, Patricia Klaas, Antonio Hardan, Julian A Martinez-Agosto, Mustafa Sahin, Charis Eng, Developmental Synaptopathies Consortium

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Translational psychiatry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 1 pooled it
9.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 1 synthesis or guideline pooled it, 113 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. The Microbiota in the Diagnosis and Treatment of Autism Spectrum Disorder.International journal of molecular sciences · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Altered Primary Somatosensory Neuron Development in a Pten Heterozygous Model for Autism Spectrum Disorder.Autism research : official journal of the International Society for Autism Research · 2025
    Article
  12. Review
  13. Genes · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Robyn M BuschDepartment of Neurology, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.
Siddharth SrivastavaDepartment of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Olivia HogueDepartment of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA.
Thomas W FrazierGenomic Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.
Patricia KlaasDepartment of Neurology, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.
Antonio HardanPsychiatry and Behavioral Sciences, Stanford University Medical Center, Stanford, CA, USA.
Julian A Martinez-AgostoDepartment of Human Genetics, University of California Los Angeles, Los Angeles, CA, USA.
Mustafa SahinDepartment of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0001-7044-2953
Charis EngGenomic Medicine Institute, Cleveland Clinic, Cleveland, OH, USA. engc@ccf.org.ORCID http://orcid.org/0000-0002-3693-5145
Developmental Synaptopathies Consortium
Boston Children's Hospital · USCleveland Clinic · USAutism Speaks · USStanford Medicine · USStanford University · USUniversity of California, Los Angeles · US

Funding

Toward better characterization and clinical trial readiness for targeting neuropsychiatric manifestations in PTEN pathogenic variantsU54NS092090 · NINDS · BOSTON CHILDREN'S HOSPITAL · PI M. Pilar Trelles · 2014 to 2026
$20.1M
NINDS NIH HHS U54 NS092090
6 · The paper itself

Abstract

Germline mutations in PTEN, the gene that encodes phosphatase and tensin homolog, have been identified in up to 20% of children with autism spectrum disorder (ASD) and macrocephaly and are associated with marked abnormalities in the white matter of the brain. This study sought to characterize the neurobehavioral phenotype of PTEN-ASD. Comprehensive neurobehavioral evaluations were conducted in 36 participants (ages 3-21 years) with PTEN-ASD and compared to two groups of controls: non-syndromic ASD with macrocephaly (Macro-ASD, n = 25) and those with PTEN mutations without ASD (PTEN-no ASD, n = 23). Linear regression analysis or Kruskal-Wallis tests were used to examine group differences on neurobehavioral measures (cognitive, behavioral, sensory, and adaptive functioning) and, for select measures, one-sample t-tests were used to compare group performance to healthy control norms. These analyses revealed a distinct neuropsychological profile associated with mutations in PTEN suggesting primary disruption of frontal lobe systems (i.e., attention, impulsivity, reaction time, processing speed, and motor coordination). Cognitive deficits in PTEN-ASD are more severe than those in PTEN-no ASD and extend to other areas of neurobehavioral function, specifically, adaptive behavior and sensory deficits. While core ASD symptoms are similar in PTEN-ASD and Macro-ASD, PTEN-ASD had lower clinical ratings of autism severity and showed more sensory abnormalities suggestive of less sensory responsiveness. Together, these results suggest that PTEN-ASD has a distinct neurobehavioral phenotype compared to idiopathic ASD that is likely to warrant special consideration for overall assessment and treatment.

Indexed as

AdolescentAutism Spectrum DisorderBrainCase-Control StudiesChildChild, PreschoolFemaleGerm-Line MutationHeterozygoteHumansLinear ModelsMaleNeuropsychological TestsPhenotypePTEN PhosphohydrolaseUnited StatesPTEN PhosphohydrolasePTEN protein, human

Identifiers

PMID31594918
PMCPMC6783427
OpenAlexW2979900173

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.